Global Treatment Resistant Depression Therapeutics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	201 Pages	TechNavio	December, 2024	INF19463359

Best Price Guarantee
Price	from $2,500
Length	201 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463359

Treatment Resistant Depression Therapeutics Market 2025-2029

The treatment resistant depression therapeutics market is forecasted to grow by USD 2061 mn during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the treatment resistant depression therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of depression, focus on rapid-acting antidepressants, and investments in mental health.

Technavio's treatment resistant depression therapeutics market is segmented as below:

By Distribution Channel

Offline
Online

By Type

Antidepressants
NMDA
Antipsychotics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of ai in drug development as one of the prime reasons driving the treatment resistant depression therapeutics market growth during the next few years. Also, increase in regulatory approvals and focus on personalized medicine will lead to sizable demand in the market.

The report on the treatment resistant depression therapeutics market covers the following areas:

Treatment Resistant Depression Therapeutics Market sizing
Treatment Resistant Depression Therapeutics Market forecast
Treatment Resistant Depression Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading treatment resistant depression therapeutics market vendors that include AbbVie Inc., Acadia Pharmaceuticals Inc., Alkermes Public Ltd. Co., AstraZeneca Plc, Axsome Therapeutics Inc., Eli Lilly and Co., Evotec SE, H Lundbeck AS, Intra-Cellular Therapies Inc, Johnson and Johnson Inc., Numinus Wellness Inc, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sage Therapeutics Inc, Stella MSO LLC dba Field Trip Health, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., and Vistagen Therapeutics Inc. Also, the treatment resistant depression therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Treatment Resistant Depression Therapeutics Market 2019 - 2023; Historic Market Size - Data Table on Global Treatment Resistant Depression Therapeutics Market 2019 - 2023 ($ million); 5.2 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on the Global Treatment Resistant Depression Therapeutics Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel: 8.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 8.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 8.3 Offline - Market size and forecast 2024-2029; Chart on Offline - Market size and forecast 2024-2029 ($ million); Data Table on Offline - Market size and forecast 2024-2029 ($ million); Chart on Offline - Year-over-year growth 2024-2029 (%); Data Table on Offline - Year-over-year growth 2024-2029 (%); 8.4 Online - Market size and forecast 2024-2029; Chart on Online - Market size and forecast 2024-2029 ($ million); Data Table on Online - Market size and forecast 2024-2029 ($ million); Chart on Online - Year-over-year growth 2024-2029 (%); Data Table on Online - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ million); Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Antidepressants - Market size and forecast 2024-2029; Chart on Antidepressants - Market size and forecast 2024-2029 ($ million); Data Table on Antidepressants - Market size and forecast 2024-2029 ($ million); Chart on Antidepressants - Year-over-year growth 2024-2029 (%); Data Table on Antidepressants - Year-over-year growth 2024-2029 (%); 9.4 NMDA - Market size and forecast 2024-2029; Chart on NMDA - Market size and forecast 2024-2029 ($ million); Data Table on NMDA - Market size and forecast 2024-2029 ($ million); Chart on NMDA - Year-over-year growth 2024-2029 (%); Data Table on NMDA - Year-over-year growth 2024-2029 (%); 9.5 Antipsychotics - Market size and forecast 2024-2029; Chart on Antipsychotics - Market size and forecast 2024-2029 ($ million); Data Table on Antipsychotics - Market size and forecast 2024-2029 ($ million); Chart on Antipsychotics - Year-over-year growth 2024-2029 (%); Data Table on Antipsychotics - Year-over-year growth 2024-2029 (%); 9.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.7 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.11 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.12 Spain - Market size and forecast 2024-2029; Chart on Spain - Market size and forecast 2024-2029 ($ million); Data Table on Spain - Market size and forecast 2024-2029 ($ million); Chart on Spain - Year-over-year growth 2024-2029 (%); Data Table on Spain - Year-over-year growth 2024-2029 (%); 11.13 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.14 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.15 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 11.16 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 14.5 Alkermes Public Ltd. Co.; Alkermes Public Ltd. Co. - Overview; Alkermes Public Ltd. Co. - Product / Service; Alkermes Public Ltd. Co. - Key offerings; SWOT; 14.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.7 Axsome Therapeutics Inc.; Axsome Therapeutics Inc. - Overview; Axsome Therapeutics Inc. - Product / Service; Axsome Therapeutics Inc. - Key offerings; SWOT; 14.8 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 14.9 Evotec SE; Evotec SE - Overview; Evotec SE - Business segments; Evotec SE - Key news; Evotec SE - Key offerings; Evotec SE - Segment focus; SWOT; 14.10 H Lundbeck AS; H Lundbeck AS - Overview; H Lundbeck AS - Product / Service; H Lundbeck AS - Key offerings; SWOT; 14.11 Intra-Cellular Therapies Inc; Intra-Cellular Therapies Inc - Overview; Intra-Cellular Therapies Inc - Product / Service; Intra-Cellular Therapies Inc - Key offerings; SWOT; 14.12 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 14.13 Numinus Wellness Inc; Numinus Wellness Inc - Overview; Numinus Wellness Inc - Product / Service; Numinus Wellness Inc - Key offerings; SWOT; 14.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.15 Sage Therapeutics Inc; Sage Therapeutics Inc - Overview; Sage Therapeutics Inc - Product / Service; Sage Therapeutics Inc - Key offerings; SWOT; 14.16 Stella MSO LLC dba Field Trip Health; Stella MSO LLC dba Field Trip Health - Overview; Stella MSO LLC dba Field Trip Health - Product / Service; Stella MSO LLC dba Field Trip Health - Key offerings; SWOT; 14.17 Sumitomo Pharma Co. Ltd.; Sumitomo Pharma Co. Ltd. - Overview; Sumitomo Pharma Co. Ltd. - Business segments; Sumitomo Pharma Co. Ltd. - Key offerings; Sumitomo Pharma Co. Ltd. - Segment focus; SWOT; 14.18 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Treatment Resistant Depression Therapeutics Market 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits37: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Distribution Channel; Exhibits39: Data Table on Comparison by Distribution Channel; Exhibits40: Chart on Offline - Market size and forecast 2024-2029 ($ million); Exhibits41: Data Table on Offline - Market size and forecast 2024-2029 ($ million); Exhibits42: Chart on Offline - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Offline - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Online - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Online - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Online - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Online - Year-over-year growth 2024-2029 (%); Exhibits48: Market opportunity by Distribution Channel ($ million); Exhibits49: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits50: Chart on Type - Market share 2024-2029 (%); Exhibits51: Data Table on Type - Market share 2024-2029 (%); Exhibits52: Chart on Comparison by Type; Exhibits53: Data Table on Comparison by Type; Exhibits54: Chart on Antidepressants - Market size and forecast 2024-2029 ($ million); Exhibits55: Data Table on Antidepressants - Market size and forecast 2024-2029 ($ million); Exhibits56: Chart on Antidepressants - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Antidepressants - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on NMDA - Market size and forecast 2024-2029 ($ million); Exhibits59: Data Table on NMDA - Market size and forecast 2024-2029 ($ million); Exhibits60: Chart on NMDA - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on NMDA - Year-over-year growth 2024-2029 (%); Exhibits62: Chart on Antipsychotics - Market size and forecast 2024-2029 ($ million); Exhibits63: Data Table on Antipsychotics - Market size and forecast 2024-2029 ($ million); Exhibits64: Chart on Antipsychotics - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Antipsychotics - Year-over-year growth 2024-2029 (%); Exhibits66: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits67: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits68: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits70: Market opportunity by Type ($ million); Exhibits71: Data Table on Market opportunity by Type ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Spain - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Spain - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Spain - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Spain - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits133: Market opportunity By Geographical Landscape ($ million); Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits135: Impact of drivers and challenges in 2024 and 2029; Exhibits136: Overview on criticality of inputs and factors of differentiation; Exhibits137: Overview on factors of disruption; Exhibits138: Impact of key risks on business; Exhibits139: Companies covered; Exhibits140: Company ranking index; Exhibits141: Matrix on companies position and classification; Exhibits142: AbbVie Inc. - Overview; Exhibits143: AbbVie Inc. - Product / Service; Exhibits144: AbbVie Inc. - Key news; Exhibits145: AbbVie Inc. - Key offerings; Exhibits146: SWOT; Exhibits147: Alkermes Public Ltd. Co. - Overview; Exhibits148: Alkermes Public Ltd. Co. - Product / Service; Exhibits149: Alkermes Public Ltd. Co. - Key offerings; Exhibits150: SWOT; Exhibits151: AstraZeneca Plc - Overview; Exhibits152: AstraZeneca Plc - Product / Service; Exhibits153: AstraZeneca Plc - Key news; Exhibits154: AstraZeneca Plc - Key offerings; Exhibits155: SWOT; Exhibits156: Axsome Therapeutics Inc. - Overview; Exhibits157: Axsome Therapeutics Inc. - Product / Service; Exhibits158: Axsome Therapeutics Inc. - Key offerings; Exhibits159: SWOT; Exhibits160: Eli Lilly and Co. - Overview; Exhibits161: Eli Lilly and Co. - Product / Service; Exhibits162: Eli Lilly and Co. - Key offerings; Exhibits163: SWOT; Exhibits164: Evotec SE - Overview; Exhibits165: Evotec SE - Business segments; Exhibits166: Evotec SE - Key news; Exhibits167: Evotec SE - Key offerings; Exhibits168: Evotec SE - Segment focus; Exhibits169: SWOT; Exhibits170: H Lundbeck AS - Overview; Exhibits171: H Lundbeck AS - Product / Service; Exhibits172: H Lundbeck AS - Key offerings; Exhibits173: SWOT; Exhibits174: Intra-Cellular Therapies Inc - Overview; Exhibits175: Intra-Cellular Therapies Inc - Product / Service; Exhibits176: Intra-Cellular Therapies Inc - Key offerings; Exhibits177: SWOT; Exhibits178: Johnson and Johnson Inc. - Overview; Exhibits179: Johnson and Johnson Inc. - Business segments; Exhibits180: Johnson and Johnson Inc. - Key news; Exhibits181: Johnson and Johnson Inc. - Key offerings; Exhibits182: Johnson and Johnson Inc. - Segment focus; Exhibits183: SWOT; Exhibits184: Numinus Wellness Inc - Overview; Exhibits185: Numinus Wellness Inc - Product / Service; Exhibits186: Numinus Wellness Inc - Key offerings; Exhibits187: SWOT; Exhibits188: Pfizer Inc. - Overview; Exhibits189: Pfizer Inc. - Product / Service; Exhibits190: Pfizer Inc. - Key news; Exhibits191: Pfizer Inc. - Key offerings; Exhibits192: SWOT; Exhibits193: Sage Therapeutics Inc - Overview; Exhibits194: Sage Therapeutics Inc - Product / Service; Exhibits195: Sage Therapeutics Inc - Key offerings; Exhibits196: SWOT; Exhibits197: Stella MSO LLC dba Field Trip Health - Overview; Exhibits198: Stella MSO LLC dba Field Trip Health - Product / Service; Exhibits199: Stella MSO LLC dba Field Trip Health - Key offerings; Exhibits200: SWOT; Exhibits201: Sumitomo Pharma Co. Ltd. - Overview; Exhibits202: Sumitomo Pharma Co. Ltd. - Business segments; Exhibits203: Sumitomo Pharma Co. Ltd. - Key offerings; Exhibits204: Sumitomo Pharma Co. Ltd. - Segment focus; Exhibits205: SWOT; Exhibits206: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits207: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits208: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits209: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits210: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits211: SWOT; Exhibits212: Inclusions checklist; Exhibits213: Exclusions checklist; Exhibits214: Currency conversion rates for US$; Exhibits215: Research methodology; Exhibits216: Information sources; Exhibits217: Data validation; Exhibits218: Validation techniques employed for market sizing; Exhibits219: Data synthesis; Exhibits220: 360 degree market analysis; Exhibits221: List of abbreviations